The role of beta cell regeneration in type 2 diabetes

October 10, 2012
The role of beta cell regeneration in type 2 diabetes
Credit: Thinkstock

The World Health Organization (WHO) has declared type 2 diabetes as the epidemic of the 21st century. A study is focusing on understanding the mechanisms underlying insulin resistance and the role of beta-cell regeneration.

Type 2 diabetes develops through a step-wise process, starting by the inability of the body to use insulin effectively which causes to produce more insulin in an attempt to compensate for this phenomenon. Eventually, the beta cells become exhausted and cannot produce enough insulin to overcome and at this point, this condition can progress to diabetes.

A substantial decrease in the number of beta cells due to extensive cell death or decreased proliferation, and/or an impairment of are considered the most likely mechanisms underlying type 2 diabetes. The European BCELL-T2D is aiming to delineate these mechanisms and study the potential of beta- in therapy.

To achieve this, scientists have characterised a mouse model carrying a mutation in the receptor that binds the fat cell-specific hormone leptin. These animals are prone to obesity and type 2 diabetes.

Results so far indicate that insulin resistance starts at 4–9 weeks of age, progresses to frank diabetes (10–18 weeks of age) and finally to advanced diabetes and its complications (after 19 weeks of age). Assessment of the beta-cell mass at each stage has shown an initial expansion in the insulin compensatory phase that disappears along the evolution of the disease.

As a therapeutic intervention, scientists are looking to overcome the proliferation shortage of beta cells by providing cyclin C, a protein that controls cell cycle entry. Ongoing research will determine if sustained beta- has the potential to prevent diabetes debut.

By studying the type 2 diabetes mouse model, scientists have revealed novel insight into the disease development and pathophysiology. Project findings hold great potential of being translated into new therapies in order to prevent and treat this devastating disease and its complications.

Explore further: Researchers find beta cell stress could trigger the development of type 1 diabetes

Related Stories

Researchers find beta cell stress could trigger the development of type 1 diabetes

March 22, 2012
In type 1 diabetes (T1D), pancreatic beta cells die from a misguided autoimmune attack, but how and why that happens is still unclear. Now, JDRF-funded scientists from the Indiana University School of Medicine have found ...

Insulin signaling is distorted in pancreases of Type 2 diabetics

December 13, 2011
Insulin signaling is altered in the pancreas, a new study shows for the first time in humans. The errant signals disrupt both the number and quality of beta cells — the cells that produce insulin.

Connexins: Providing protection to cells destroyed in Type 1 diabetes

November 7, 2011
Type 1 diabetes is a lifelong disease characterized by high levels of sugar (glucose) in the blood. It is caused by the patient's immune system attacking and destroying the cells in their pancreas that produce the hormone ...

Hormone discovered that preserves insulin production and beta cell function in diabetes

July 2, 2012
(Medical Xpress) -- Researchers at Duke University Medical Center have found protective, anti-diabetic functions for a hormone that, like insulin, is produced by the islet cells of the pancreas. The new hormone was found ...

Recommended for you

Diabetes pill might replace injection to control blood sugar

October 17, 2017
(HealthDay)— An injectable class of diabetes medication—called glucagon-like peptide-1 or GLP-1—might one day be available in pill form, research suggests.

Skimping on sleep may contribute to gestational diabetes

October 17, 2017
The amount of time spent sleeping in the United States has dropped significantly in the past twenty years with almost a quarter of women and 16 percent of men experiencing insufficient sleep. Now, a new study has found that ...

Artificial pancreas performs well in clinical trial

October 16, 2017
During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week, multi-site clinical trial showed significant improvements in two key measures of well-being in people living ...

Omega-6 fats may help prevent type 2 diabetes

October 11, 2017
The risk of developing type 2 diabetes could be significantly reduced by eating a diet rich in omega-6 polyunsaturated fats, a new study suggests.

Where there's type 1 diabetes, celiac disease may follow

October 10, 2017
(HealthDay)—Parents of young children with type 1 diabetes need to be on the lookout for symptoms of another autoimmune condition—celiac disease, new research suggests.

Type 1 diabetes and the microbiota—MAIT cells as biomarkers and new therapeutic targets

October 10, 2017
Together with colleagues from AP-HP Necker–Enfants Malades Hospital in Paris, scientists from the Cochin Institute (CNRS / INSERM / Paris Descartes University) have discovered that the onset of type 1 diabetes is preceded ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.